[Pubmed] Diabetes mellitus aggravates humoral immune response in myasthenia gravis by promoting differentiation and acti

[RSS-Bot]

Clin Immunol. 2022 Oct 18:109141. doi: 10.1016/j.clim.2022.109141. Online ahead of print.

ABSTRACT

Myasthenia gravis (MG) is a T-cell-dependent, antibody-mediated autoimmune disease. Diabetes mellitus (DM) is a chronic metabolic disease characterized by hyperglycemia and emerging evidence indicates its profound impacts on the immune homeostasis. Previous studies and our data showed DM might serve as an independent risk factor of MG, yet the underlying immune and molecular mechanisms remain to be addressed. Our study observed that circulating Tfh (cTfh) cells were increased in MG patients with DM and expressed a high level of ICOS. Besides, positive correlations between activated cTfh cells and plasmablasts were documented. Further studies demonstrated hyperglycemia promoted the differentiation and activation of Tfh cells which, in turn, caused abnormal plasmablasts differentiation and antibody secretion through the mTOR signaling pathway. These results indicated DM might aggravate the aberrant humoral immunity in MG patients by augmenting Tfh cells differentiation and function and tight glycemic control might be beneficial for MG patients with DM.

PMID:36270469 | DOI:10.1016/j.clim.2022.109141


Source: https://pubmed.ncbi.nlm.nih.gov/3627046 ... 0&v=2.17.8